Determination of 25OHD in Serum Based on Quadrupole-Linear Ion Trap Tandem Mass Spectrometric Technique

被引:0
|
作者
Xie J. [1 ]
Yi K.-K. [1 ]
Gao W.-J. [1 ]
Liu H. [2 ,3 ]
Li J.-L. [2 ,3 ]
Huang Z.-J. [1 ]
Liu M.-Y. [1 ]
Yu Q.-N. [2 ]
Wang H.-W. [2 ,3 ]
Jiang Y. [1 ]
Dai X.-H. [1 ]
Fang X. [1 ]
机构
[1] Center for Advanced Measurement Science, Technology Innovation Caller of Mass Spectrometry for State Market Regulation, National Institute of Metrology, Beijing
[2] Changzhou Panna Instrument Co., Ltd.., Changzhou
[3] Anhui Limu Medical Instrument Co.. Ltd., Liuan
关键词
25OHD; isotope dilution mass spectrometry; linear ion trap; liquid chromatography tandem mass spectrometry (LC-MS/MS); quadrupole;
D O I
10.7538/zpxb.2022.0103a
中图分类号
学科分类号
摘要
Vitamin D deficiency and insufficiency is a global health issue that afflicts people of different age groups all over the world. As a reliable indicator for the evaluation of vitamin D, 25OHD is usually determined by LC-MS/MS. The tandem mass spectrometry based on ion trap has the characteristics of simple structure and high sensitivity. However, there are some problems such as narrow linear range and space charge effect, which limit its analysis of trace substances in complex matrix samples. In this study, the device and technology of a new quadrupole linear ion trap mass spectrometry was used to reduce the space charge interference of trace or ultra trace target ions by high abundance impurity ions in complex matrices. For the first time, isotope dilution mass spectrometry for accurate measurement of serum 25()HD was established by QLIT-6610MD, which is quadrupole-linear ion trap tandem mass spectrometer, and was independently developed by Technology Innovation Center of Mass Spectrometry for State Market Regulation. Center for Advanced Measurement Science. National Institute of Metrology. Serum samples were precipitated with methanol, extracted with w-hexane, dried with liquid nitrogen, redissolved in the initial mobile phase, and determined by QLIT-6610MD. The matrix-matched standard curve was used for quantification. The linear ranges of 25OHD2and 25OHD3were in the range of 0. 78-50 ,µg/L and 1. 56-100 µg/L with >0. 999 9, respectively. The detection and quantification limits of 25OHD, and 25OHD: were 0. 06, 0. 12 µ/L and 0. 02, 0. 06 p.g/L. respectively. The precision of quality control was better than 4. 06%. The recoveries ranged from 99. 25 ?/o to 108. 38% , and the coefficients of variation were all less than 5. 1 %. After the method confirmation, the quantitative results of clinical samples were compared with triple quadrupole tandem mass spectrometry. 50 Clinical serum samples were measured and compared by QLIT-6610MD. AB 4500MD and YS EXACT 9900MD. The correlation and consistency of the data were analyzed by Pearson and Bland-Altman. The correlation coefficient of the three groups data was 998 0. P<0. 01, and the results of Bland-Altman analysis showed good consistency, indicating that the results measured by the three instruments were consistent, which meant that QLIT-6610MD can meet the needs of clinical diagnosis. QLIT-6610MD achieved the same level of triple quadrupole mass spectrometry to determine the concentration of 25OHD in serum. It can not only become a new choice for clinical mass spectrometry, but also lay a foundation for the development of domestic mass spectrometer. Based on the direct axial coupling technology of quadrupole and linear ion trap. QLIT-6610MD can greatly reduce the interference of matrix ions and make the ion trap detect target ions more effectively. This technology has a strong potential to further improve the measurement accuracy of trace or ultra trace targets in complex matrices. In the future, it can be applied to mass spectrometry monitoring scenarios that needs to meet the requirements of high accuracy, high sensitivity. on-site speed and low cost at the same time. © 2023 Chinese Society for Mass Spectrometry. All rights reserved.
引用
收藏
页码:13 / 24
页数:11
相关论文
共 30 条
  • [1] JUKIC A M Z, HOOFNAGLE A N., LUTSEY P L., Measurement of vitamin D for epidemiologic and clinical research: shining light on a complex decision, American Journal of Epidemiology, 187, 4, pp. 879-890, (2018)
  • [2] JEON S, SHIN E., Exploring vitamin D metabo¬lism and function in cancer, Experimental &-Molecular Medicine, 50, 4, pp. 1-14, (2018)
  • [3] de la GUIA-GALIPIENSO F, MARTINEZ-FERRAN M, VALLECILLO N, LA VIE C J, SANCHIS-GOMAR F, PAREJA-GALEANO H., Vitamin D and cardiovascular health, Clinical Nutrition, 40, 5, pp. 2946-2957, (2021)
  • [4] NITSA A, TOUTOUZA M, MACHAIRAS N, MARIOLIS A, PHILIPPOU A, KOUTSIL-IERIS M., Vitamin D in cardiovascular disease, In Vivo, 32, 5, pp. 977-981, (2018)
  • [5] MITRI J, PITTAS A G., Vitamin D and diabetes [J], Endocrinol Metab Clin North Am, 43, 1, pp. 205-232, (2014)
  • [6] TRIPKOVIC L, LAMBERT H, HART K, SMITH C P, BUCCA G, PENSON S, CHOPE G, HYPPONEN E, BERRY J, VIETH R, LANHAM-NEW S., Comparison of vitamin D2 and vitamin D3 supplementation in raising serum 25-hydroxyvitamin D status
  • [7] a systematic review and meta-analysis[J], Am J Clin Nutr, 95, 6, pp. 1357-1364, (2012)
  • [8] LIPS P., Relative value of 25(OH)D and l,25(OH)2D measurements, Journal of Bone and Mineral Research, 22, 11, pp. 1668-1671, (2007)
  • [9] HOLICK M F, BINKLEY N C, BISCHOFF-FERRARI H A, GORDON C M, HANLEY D A, HEANEY R P, MURAD M H, WEAVER C M., Evaluation, treatment, and prevention of vitamin D deficiency: an endocrine society clinical practice guideline, J Clin Endocrinol Metab, 96, 7, pp. 1911-1930, (2011)
  • [10] MAKRIS K, BHATTOA H P, CAVALIER E, PHINNEY K, SEMPOS C T, ULMER C Z, VASIKARAN S D, VESPER H, HEIJBOER A C., Recommendations on the measurement and the clinical use of vitamin D metabolites and vita¬min D binding protein-a position paper from the IFCC committee on bone metabolism, Clin Chim Acta, 517, pp. 171-197, (2021)